GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,405,567 | -31.7% | 370,862 | -0.9% | 0.00% | – |
| Q2 2023 | $2,058,574 | +24.3% | 374,286 | -2.8% | 0.00% | – |
| Q1 2023 | $1,655,891 | -0.9% | 385,091 | -9.4% | 0.00% | – |
| Q4 2022 | $1,670,823 | -24.0% | 425,146 | +2.8% | 0.00% | -100.0% |
| Q3 2022 | $2,198,000 | -18.8% | 413,698 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $2,707,000 | -8.8% | 412,585 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $2,967,000 | -0.3% | 404,176 | -3.8% | 0.00% | – |
| Q4 2021 | $2,975,000 | -72.7% | 420,184 | -3.5% | 0.00% | -100.0% |
| Q3 2021 | $10,917,000 | +0.1% | 435,516 | +7.4% | 0.00% | 0.0% |
| Q2 2021 | $10,906,000 | -1.1% | 405,430 | +4.6% | 0.00% | 0.0% |
| Q1 2021 | $11,027,000 | +160.1% | 387,472 | +159.2% | 0.00% | +100.0% |
| Q4 2020 | $4,239,000 | -8.4% | 149,495 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $4,626,000 | – | 149,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |